▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Cellarity to Present at 44th Annual J.P. Morgan Healthcare Conference

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that Chief Executive Officer Ted Myles will...

Immagine

Company to highlight outlook for pipeline and platform momentum in 2026

SOMERVILLE, Mass.: Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that Chief Executive Officer Ted Myles will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:00 a.m. PST. The presentation will update on the progress of Cellarity’s innovative Cell State-Correcting platform and pipeline, including its clinical program CLY-124, a first-in-class oral globin-switching investigational therapy for sickle cell disease (SCD).

About Cellarity

Founded by Flagship Pioneering in 2019, Cellarity is pioneering a fundamentally new approach to drug discovery that corrects whole cell-state dysfunction to solve complex diseases. The Company’s proprietary drug discovery platform leverages advanced transcriptomics to comprehensively understand gene networks and applies the power of dynamic AI modeling to predict and design oral Cell State-Correcting therapeutics that can precisely regulate genetic switch mechanisms to restore proper cell function. The Company’s lead asset, CLY-124, is designed to treat sickle cell disease through a novel globin-switching mechanism and is under evaluation in a Phase 1 clinical study. Additional candidates designed by the platform are advancing for indications in hematology and immunology, and Cellarity has an active collaboration with Novo Nordisk targeting metabolic dysfunction-associated steatohepatitis (MASH). For more information visit www.cellarity.com.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Bentley Systems Announces Fourth Quarter and Full Year 2025 Results and…

Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced results for the quarter ended December 31,…

Docebo Reports Fourth Quarter and Fiscal Year 2025 Results

Docebo Inc. (NASDAQ: DCBO; TSX:DCBO) (“Docebo” or the “Company”), a leading learning platform provider with a foundation in artificial intelligence (AI)…

NIQ Announces Strong Fourth Quarter and Full Year 2025 Results

NIQ Global Intelligence plc (NYSE: NIQ) (the “Company”, or “NIQ”), a leading global consumer intelligence company, today announced financial results for…

RingCentral to Present at Morgan Stanley Investor Conference

$rng #AI--RingCentral, Inc. (NYSE: RNG), a global leader in AI-powered business communications, today announced that members of its management team are…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!